DJ
Daly James M
Director
OFFICERM
Insider track record
ExecutiveAcross 5 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Explore the full record of transactions filed by Daly James M, Director. Director active across 5 companies, notably Halozyme Therapeutics, INC.. Aggregated, 18 filings have been recorded. Breakdown: 0 buy · 1 sell. Total volume traded: €398k. Activity tracked since 5 May 2021. The latest transaction was filed on 27 May 2026 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations18 total
454 sharesCommon StockSEC:0001628280-26-044307:0
8,107 sharesCommon StockSEC:0001560782-26-000002:0
2,851 shares0Common StockSEC:0001061983-26-000061:0
9,470 shares@ US$65.0623.9% of flowCommon StockSEC:0001628280-25-009079:0
714 shares0Common StockSEC:0000950170-24-078750:0
6,652 sharesCommon StockSEC:0001415889-24-015087:0
20,000 shares@ US$100.4576.1% of flowCommon StockSEC:0000899243-24-000243:0
10,000 shares@ US$43.711100.0% of flowCommon StockSEC:0001415889-23-012257:0
1,198 shares0Common StockSEC:0000899243-23-016057:0
3,059 sharesCommon StockSEC:0001209191-23-034695:0
8,065 shares0Common StockSEC:0001415889-23-007689:0
60,414 shares0Common StockSEC:0001628280-23-000422:0
35,082 shares0Common StockSEC:0001628280-22-024219:0
6,206 shares0Restricted Stock UnitSEC:0001179110-22-002908:0
13,568 shares0Common StockSEC:0001628280-22-000412:0
13,568 shares0Common StockSEC:0001628280-22-000412
5,230 sharesRestricted Stock UnitSEC:0001179110-21-004971
5,230 shares0Restricted Stock UnitSEC:0001179110-21-004971:0
About Daly James M
James M. Daly is a Director at HALOZYME THERAPEUTICS, INC. and BELLICUM PHARMACEUTICALS, INC. In this role, he is involved in the governance of the company and strategic decision-making. His expertise in the pharmaceutical sector allows him to make significant contributions.